These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 25468749)
61. Long term prognosis of medullary thyroid carcinoma in 39 patients. Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961 [TBL] [Abstract][Full Text] [Related]
62. Male patients with papillary thyroid cancer have a higher risk of extranodal extension. Hei H; Zhou B; Gong W; Zheng C; Qin J Int J Clin Oncol; 2022 Apr; 27(4):648-654. PubMed ID: 35000041 [TBL] [Abstract][Full Text] [Related]
63. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Lee BJ Ann Surg Oncol; 2011 Nov; 18(12):3486-92. PubMed ID: 21553141 [TBL] [Abstract][Full Text] [Related]
64. Metastatic Risk Profile of Microscopic Lymphatic and Venous Invasion in Medullary Thyroid Cancer. Machens A; Lorenz K; Weber F; Dralle H Horm Metab Res; 2021 Sep; 53(9):588-593. PubMed ID: 34496409 [TBL] [Abstract][Full Text] [Related]
65. Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer. Hei H; Li Y; Luo Z; Chai X; Zhang H; Zheng C; Zhou B; Gong W; Qin J Langenbecks Arch Surg; 2022 Jun; 407(4):1647-1652. PubMed ID: 35146548 [TBL] [Abstract][Full Text] [Related]
66. Ultrasonographic features of cervical lymph node metastases from medullary thyroid cancer: a retrospective study. Ni X; Xu S; Zhan W; Zhou W BMC Med Imaging; 2022 Aug; 22(1):151. PubMed ID: 36038830 [TBL] [Abstract][Full Text] [Related]
67. Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Machens A; Dralle H Ann Surg Oncol; 2009 Jan; 16(1):171-6. PubMed ID: 18982392 [TBL] [Abstract][Full Text] [Related]
68. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476 [TBL] [Abstract][Full Text] [Related]
69. Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Lee BJ World J Surg; 2010 Nov; 34(11):2558-63. PubMed ID: 20703463 [TBL] [Abstract][Full Text] [Related]
70. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457 [TBL] [Abstract][Full Text] [Related]
71. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137 [TBL] [Abstract][Full Text] [Related]
72. Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma. Li YR; Chen ST; Hseuh C; Chao TC; Ho TY; Lin JD J Formos Med Assoc; 2016 Aug; 115(8):665-71. PubMed ID: 26239193 [TBL] [Abstract][Full Text] [Related]
73. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes. Rowe ME; Ozbek U; Machado RA; Yue LE; Hernandez-Prera JC; Valentino A; Qazi M; Brandwein-Weber M; Liu X; Wenig BM; Urken ML Endocr Pathol; 2018 Mar; 29(1):80-85. PubMed ID: 29396810 [TBL] [Abstract][Full Text] [Related]
74. Predictive factors that influence the course of medullary thyroid carcinoma. Pazaitou-Panayiotou K; Chrisoulidou A; Mandanas S; Tziomalos K; Doumala E; Patakiouta F Int J Clin Oncol; 2014; 19(3):445-51. PubMed ID: 23832286 [TBL] [Abstract][Full Text] [Related]
75. Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging. Wang Q; Takashima S; Fukuda H; Takayama F; Kobayashi S; Sone S Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):842-8. PubMed ID: 10448729 [TBL] [Abstract][Full Text] [Related]
76. Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma? Paessler M; Kreisel FH; LiVolsi VA; Akslen LA; Baloch ZW Int J Surg Pathol; 2002 Oct; 10(4):267-72. PubMed ID: 12490976 [TBL] [Abstract][Full Text] [Related]
77. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma]. Yue C; Zhao X; Tian C; Jin Y; Liu H Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040 [TBL] [Abstract][Full Text] [Related]
78. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma. Shin CH; Roh JL; Song DE; Cho KJ; Choi SH; Nam SY; Kim SY Am J Surg; 2020 Oct; 220(4):925-931. PubMed ID: 32081409 [TBL] [Abstract][Full Text] [Related]